Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Drug inhibition of glycosyltransferases: Mycobacteria, including the species that causes tuberculosis (TB), synthesize a complex cell wall that helps to support and protect the bacterial cells. The major components of the cell wall include complex heteropolysaccharides that are synthesized in the periplasmic space. Zhang et al. determined the cryo–electron microscopy structures of two transmembrane glycosyltransferase enzyme complexes that use a lipid-anchored sugar donor to append arabinose units to the cell wall polysaccharides. They also captured the anti-TB drug ethambutol bound within these complexes and observed that it binds in a site overlapping both donor and acceptor sugars. Mapping of resistance mutants provides a structural understanding of how resistance emerges while preserving function of the enzyme and may help to guide the development of next-generation anti-TB drugs that target these enzymes. Science , this issue p. 1211
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652
Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., et al. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798319011471 · Cited by 7,953
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Goddard, T. D., Huang, C. C., Meng, E. C., Pettersen, E. F., Couch, G. S., Morris, J. H., & Ferrin, T. E. (2018) · Protein Science · doi:10.1002/pro.3235 · Cited by 5,267
Gctf: Real-time CTF determination and correction
Zhang, K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,537
Cited by
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis
Goossens, S. N., Sampson, S. L., & Van Rie, A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00141-20 · Cited by 180
“Ethambutol (EMB) exerts its bacteriostatic activity by inhibiting the production of arabinogalactan, a mycobacterial cell wall constituent (110, 111).”
BackgroundMycobacterium smegmatis: The Vanguard of Mycobacterial Research
Sparks, I. L., Derbyshire, K. M., Jacobs, W. R., & Morita, Y. S. (2023) · Journal of Bacteriology · doi:10.1128/jb.00337-22 · Cited by 149
“ferase activity by binding a region adjacent to the catalytic site (144).”
BackgroundMycobacterium tuberculosis : Pathogenesis and therapeutic targets
Yang, J., Zhang, L., Qiao, W., & Luo, Y. (2023) · MedComm · doi:10.1002/mco2.353 · Cited by 109
Self-citationIdentification and assessment of cardiolipin interactions with E. coli inner membrane proteins
Corey, R. A., Song, W., Duncan, A. L., Ansell, T. B., Sansom, M. S. P., & Stansfeld, P. J. (2021) · Science Advances · doi:10.1126/sciadv.abh2217 · Cited by 81
Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall
Batt, S. M., Burke, C., Moorey, A. R., & Besra, G. S. (2020) · The Cell Surface · doi:10.1016/j.tcsw.2020.100044 · Cited by 80
“, 2009), and structural studies have demonstrated ethambutol binding to the active site of EmbC (PDB ID: 7BVE) (Zhang et al., 2020).”
BackgroundInfluentialSelf-citationIminosugars as glycosyltransferase inhibitors
Conforti, I., & Marra, A. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00382h · Cited by 63
Sharma, A., Rosa, M. D., Singla, N., Singh, G., Barnwal, R. P., & Pandey, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01833 · Cited by 64
Barilar, I., Battaglia, S., Borroni, E., Brandão, A. P., Brankin, A. E., Cabibbe, A. M., Carter, J. J., Chetty, D., Cirillo, D. M., Claxton, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44325-5 · Cited by 55
Bifunctional modalities for repurposing protein function
Modell, A. E., Lai, S., Nguyen, T. M., & Choudhary, A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.06.005 · Cited by 53
Wang, W., Wang, J., Hu, Z., Yan, X., Gao, Q., Li, X., Zheng, J., Li, B., Wu, Y., & Liao, Y. (2024) · Aggregate · doi:10.1002/agt2.715 · Cited by 57
Zheng, S., Gu, Y., Gu, Y., Zhao, Y., Li, L., Wang, M., Jiang, R., Yu, X., Chen, T., & Li, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae696 · Cited by 49
“For example, the biosynthesis of cell wall components such as Rv3806c, DprE1, and the Emb proteins have become attractive targets for potent anti-Mtb drug research and development [7–9].”
Self-citationBon, C. L., Michon, B., Popot, J., & Zoonens, M. A. (2021) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583521000044 · Cited by 49
“White’s database have been included in the list (Wang and Sigworth, 2009; Glavier et al., 2020; Hua et al., 2020; McDowell et al., 2020; Yao et al., 2020; Zhang et al., 2020)).”
BackgroundBacterial cell envelope-targeting antibiotics
Ntallis, C., Martin, N. I., Edwards, A. M., & Weingarth, M. H. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01247-x · Cited by 55
“High-resolution structures show that ethambutol binds similarly to all three Emb proteins, competing with the arabinose moiety of DPA for the active site 151,152 .”
Emerging structural insights into C-type glycosyltransferases
Alexander, J. A. N., & Locher, K. P. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102547 · Cited by 42
Marando, V. M., Kim, D. E., Calabretta, P. J., Kraft, M. B., Bryson, B. D., & Kiessling, L. L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07430 · Cited by 39
Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis
Xu, X., Dong, B., Peng, L., Gao, C., He, Z., Wang, C., & Zeng, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1056608 · Cited by 43
Target Identification in Anti-Tuberculosis Drug Discovery
Capela, R., Félix, R., Clariano, M., Nunes, D., Perry, M. D. J., & Lopes, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310482 · Cited by 41
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
Liu, L., Kong, C., Fumagalli, M., Savková, K., Xu, Y., Huszár, S., Sammartino, J. C., Fan, D., Chiarelli, L. R., Mikušová, K., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112773 · Cited by 37
Edwards, B. D., & Field, S. K. (2022) · Drugs · doi:10.1007/s40265-022-01817-w · Cited by 40
“Ethambutol is another agent that targets this middle layer by inhibiting the arabinosyl transferase enzyme [21].”
BackgroundThe Adverse Effects of Tuberculosis Treatment: A Comprehensive Literature Review
Mereškevičienė, R., & Danila, E. (2025) · Medicina · doi:10.3390/medicina61050911 · Cited by 35
“These enzymes are important in cell wall biosynthesis [58].”
Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
Poulton, N. C., & Rock, J. M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.997283 · Cited by 40
“Further, structural and/or biochemical approaches can be used to identify the target of a particular compound, helping to differentiate between a direct or an indirect mechanism for a specific chemical-genetic interaction (Pellecchia et al., 2002; Zhang et al., 2020; Ottavi et al., 2022).”
BackgroundSensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection
Wu, X., Wu, Y., Zheng, R., Tang, F., Qin, L., Lai, D., Zhang, L., Chen, L., Yan, B., Yang, H., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051678 · Cited by 38
“Recently, the structures of arabinosyltrans-ferases targeted by the anti-TB drug ethambutol have been elucidated (Zhang et al, 2020a; Zhang et al, 2020b).”
Self-citationMetabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance
Singha, B., Murmu, S., Nair, T., Rawat, R. S., Sharma, A. K., & Soni, V. (2024) · Metabolites · doi:10.3390/metabo14010063 · Cited by 32
Calcagno, A., Coppola, N., Sarmati, L., Tadolini, M., Parrella, R., Matteelli, A., Riccardi, N., Trezzi, M., Biagio, A. D., Pirriatore, V., et al. (2024) · Infection · doi:10.1007/s15010-024-02183-3 · Cited by 33
“Ethambutol is a bacteriostatic anti-mycobacterial agent that inhibits the embA, embB, and embC arabinosyl-transferases of actively replicating mycobacteria, thus preventing mycobacterial cell wall formation and cell division [119, 120].”
BackgroundSchami, A., Islam, M. N., Belisle, J. T., & Torrelles, J. B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1274175 · Cited by 34
“…et al., 2007 EMB Inhibits M.tb arabinosyltransferases to interfere with the biosynthesis of arabinose-containing cell envelope components and prevent bacterial division DS-TB Escuyer et al., 2001; Zhang et al., 2003; Amin et al., 2008; Goude et al., 2009; Zhang et al., 2020; (AG) polysaccharide.”
BackgroundThiede, J. M., Dillon, N. A., Howe, M. D., Aflakpui, R., Modlin, S. J., Hoffner, S., Valafar, F., Minato, Y., & Baughn, A. D. (2022) · mBio · doi:10.1128/mbio.00439-21 · Cited by 32
“EMB was chosen to target the arabinosyl transferases that are essential for synthesis of the arabinogalactan layer of the mycobacterial envelope (53).”
MethodYan, M., Zheng, D., Li, S., Ding, X.-Y., Wang, C., Guo, X.-P., Zhan, L., Jin, Q., Yang, J., & Sun, Y. (2022) · Science Advances · doi:10.1126/sciadv.add5907 · Cited by 32
Identification of d-arabinan-degrading enzymes in mycobacteria
Al-Jourani, O., Benedict, S. T., Ross, J., Layton, A. J., van der Peet, P. L., Marando, V. M., Bailey, N. P., Heunis, T. D. J., Manion, J., Mensitieri, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37839-5 · Cited by 27
“Ethambutol targets the arabinosyltransferase proteins in the cell envelope of mycobacteria that are responsible for biosynthesis of the polysaccharide 9 .”
Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis
Tan, Y. Z., Rodrigues, J., Keener, J. E., Zheng, R. B., Brunton, R., Kloss, B., Giacometti, S. I., Rosário, A. L., Zhang, L., Niederweis, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17202-8 · Cited by 26
Self-citationCell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets
Shaku, M. T., Ealand, C. S., & Kana, B. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603382 · Cited by 29
“EmbA,B,C Ethambutol (EMB) Inhibit periplasmic arabinogalactan biosynthesis Clinical studies (Zhang et al., 2020) FabH Thiolactomycin analogs Inhibit mycolic acid biosynthesis in vitro (Senior et al.”
BackgroundRevolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon
Kufa, M., Finger, V., Kovar, O., Soukup, O., Torruellas, C., Roh, J., & Korábečný, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.01.023 · Cited by 27
“During the first two months, isoniazid (INH), rifampicin (RIF), ethambutol (EMB) and pyrazinamide (PZA) are administered, followed by four months of INH and RIF therapy.”
Influentialvan der Klugt, T. T., van den Biggelaar, R. H. G. A., & Saris, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2370979 · Cited by 26
“…is still unknown, but elongation is known to require α-(1 → 5)-arabinosyl- transferase embc, one of the major drug targets of the antibiotic ethambutol, while branching requires α-(1 → 3)-arabinosyltransferase Aftc and possibly AftD (Birch et al. 2008; Škovierová et al. 2009; Zhang et al. 2020).”
Shimokawa, M., Ishiwata, A., Kashima, T., Nakashima, C., Li, J., Fukushima, R., Sawai, N., Nakamori, M., Tanaka, Y., Kudo, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41431-2 · Cited by 25
“The antimycobacterial drug ethambutol, which targets the biosynthesis of D -arabinan, has been widely studied as a potential therapy for tuberculosis and other mycobacterial infections 43 .”
Self-citationFluorogenic Probes of the Mycobacterial Membrane as Reporters of Antibiotic Action
Wuo, M. G., Dulberger, C. L., Warner, T. C., Brown, R. A., Sturm, A., Ultee, E., Bloom‐Ackermann, Z., Choi, C., Zhu, J., Garner, E. C., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c00617 · Cited by 22
Diab, A. I., Dickerson, H., & Musaimi, O. A. (2025) · Pharmaceuticals · doi:10.3390/ph18010070 · Cited by 24
“Chemical structure of EMB and the interactions that EMB performs within the embB active site [55 Chemical structure of EMB and the interactions that EMB performs within the embB active site [55].”
InfluentialBendre, A. D., Peters, P. J., & Kumar, J. (2021) · The Journal of Membrane Biology · doi:10.1007/s00232-021-00179-w · Cited by 22
Cryo-EM snapshots of mycobacterial arabinosyltransferase complex EmbB2-AcpM2
Zhang, L., Zhao, Y., Gao, R., Li, J., Yang, X., Gao, Y., Zhao, W. G., Gurcha, S. S., Veerapen, N., Batt, S. M., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00726-6 · Cited by 23
Self-citationEisenhaber, B., Sinha, S., Jaladanki, C. K., Shitov, V. A., Tan, Q. W., Sirota, F. L., & Eisenhaber, F. (2021) · Biology Direct · doi:10.1186/s13062-021-00291-w · Cited by 22
“The eight essentially full-length hits with best E-values and sequence coverage > 90% are tabulated: 5ezm, crystal structure of ArnT from Cupriavidus metallidurans in the apo state [58], 5f15 is the same as 5ezm but with undecaprenyl phosphate as analogue for a lipid-linked sugar substrate; 6s7t, cryo-EM structure of…”
BackgroundSingh, P., Jamal, S., Ahmed, F., Saqib, N., Mehra, S., Ali, W., Roy, D., Ehtesham, N. Z., & Hasnain, S. E. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.034 · Cited by 23
“Apart from these genes, embC , embA , and embB are also associated with resistance to ethambutol (EMB) [22] which is a first-line drug.”
BackgroundGong, Y., Wei, C., Wang, J., Mu, N., Lu, Q., Wu, C., Yan, N., Yang, H., Zhao, Y., Yang, X., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302858120 · Cited by 21
“The association is tight as the AcpM subunit was copurified endogenously from the expressing host strain, and mainly mediated by electrostatic interaction via the positively charged region of GT-C enzymes and the negatively charged AcpM (10, 30, 38, 42) (SI Appendix, Fig.”
InfluentialSelf-citationBai, L., & Li, H. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.12.009 · Cited by 20
Rossini, N. D. O., & Dias, M. V. B. (2023) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2022-0261 · Cited by 25
“The complex EmbA-EmbB-AcpM catalyzes the transfer of an arabinose molecule from the acceptor to the donor producing a 1-3 linkage between the arabinose residue and the arabinan receptor, while the complex EmbC-Acp)M is involved in the extension of the arabinan chain, following a 1-5 linkage (Zhang et al., 2020; Bendre…”
InfluentialMycobacterium tuberculosis and its clever approaches to escape the deadly macrophage
Krishnan, V., Nath, S., Nair, P., & Das, B. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03735-9 · Cited by 17
Wang, S., Cai, X., Yu, W., Zeng, S., Zhang, J., Guo, L., Gao, Y., Lu, Z., Hameed, H. M. A., Fang, C., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02763-21 · Cited by 16
“abscessus is intrinsic to EMB even though EmbC is the target of EMB (24).”
BackgroundSelf-citationPermeability of TB drugs through the mycolic acid monolayer: a tale of two force fields
Basu, S., Mandal, S., & Maiti, P. K. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d4cp02659d · Cited by 16
Bwalya, P., Solo, E. S., Chizimu, J. Y., Shrestha, D., Mbulo, G., Thapa, J., Nakajima, C., & Suzuki, Y. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102184 · Cited by 15
Wang, Y., Chen, Y., Ji, J., Fan, D., Lin, A., Xiang, L., & Shao, J.-Z. (2022) · Journal of Virology · doi:10.1128/jvi.00791-22 · Cited by 15
Self-citationLiu, Y., Hu, X., Yang, L., Xu, R., Xu, Y., Ma, W., Alam, M. S., Zhang, T., Chai, X., Lei, Y., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01703 · Cited by 15
Lin, X., Kurz, J. L., Patel, K. M., Wun, S. J., Hussein, W. M., Lonhienne, T. G. A., West, N. P., McGeary, R. P., Schenk, G., & Guddat, L. W. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004665 · Cited by 15
Self-citationChen, X., Chen, J., Yan, B., Zhang, W., Guddat, L. W., Liu, X., & Rao, Z. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002835117 · Cited by 15
“Structures of several drug targets that are involved in the biosynthesis and transport of cell wall components, such as arabinosyltransferases and MmpL3, have been determined recently (3, 4).”
BackgroundSelf-citationDe, K., Belardinelli, J. M., Pandurangan, A. P., Ehianeta, T. S., Lian, E., Palčeková, Z., Lam, H., Juarrero, M. G., Bryant, J. M., Blundell, T. L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403206121 · Cited by 14
“None of the mutations were predicted to impact the dimerization of EmbC or to affect the binding affinity with AcpM (32).”
InfluentialGenome-scale metabolic modeling in antimicrobial pharmacology
Zhu, Y., Zhao, J., & Li, J. (2022) · Engineering Microbiology · doi:10.1016/j.engmic.2022.100021 · Cited by 14
Self-citationStructure and assembly of the MmpL5/MmpS5 efflux transporter from Mycobacterium tuberculosis
Xiong, Z., Yang, X., Wang, S., Smart, C. J., Sisson, H. M., Lin, Z., Hu, T., Ran, Y., Xu, C., Yang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60365-5 · Cited by 13
“4a, d), indicating that AcpM is in its holo-form 44 , which inserts into the gap between the two adjacent MmpL5 and phospholipid molecules.”
Self-citationGao, S., Wu, F.-Y., Gurcha, S. S., Batt, S. M., Besra, G. S., Rao, Z., & Zhang, L. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01643-8 · Cited by 13
“1c), indicating that Rv3806c is not a molecular target of EMB.”
BackgroundInfluentialSelf-citationStructural insights into terminal arabinosylation of mycobacterial cell wall arabinan
Liu, Y., Brown, C. M., Erramilli, S. K., Su, Y.-C., Guu, S.-Y., Tseng, P., Wang, Y.-J., Duong, N. H., Tokarz, P., Kloss, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58196-5 · Cited by 13
“In contrast, ACP is absent in the structures ofAftB and AftA, although they both feature positively charged surfaces on their cyto-plasm domains (Supplementary Fig.”
InfluentialSelf-citationThe Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation
Lepori, I., Jackson, K., Liu, Z., Chordia, M. D., Wong, M., Rivera, S. L., Roncetti, M., Poliseno, L., Freundlich, J. S., Pires, M. M., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01062 · Cited by 13
Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity
Barliana, M. I., Afifah, N. N., Yunivita, V., & Ruslami, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1118102 · Cited by 13
“EMB has a specific mechanism as a therapy for tuberculosis (Palomino and Martin, 2014; Lee and Nguyen, 2020; Zhang et al., 2020; National Center for Biotechnology Information, 2021).”
BackgroundWang, X., Feng, L., Li, M., Dong, W., Luo, X., & Shang, D. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130415 · Cited by 12
Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians
Mason, M., Gregory, E. R., Foster, K., Klatt, M. E., Zoubek, S., & Eid, A. J. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac287 · Cited by 12
Status of macromolecular crystallography beamlines at SSRF
Kong, H., Zhou, H., Qin, X., Liu, K., Zhang, K., Wang, X.-Y., Wang, W., Wang, Z., Wang, S., Wang, Y., et al. (2024) · Journal of Synchrotron Radiation · doi:10.1107/s1600577524011597 · Cited by 11
Self-citationCombating Multi-drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends
Kumar, G., Mondal, P., Kadam, A., Dhamija, I., Singh, R. P., Nathiya, D., & Kumar, S. (2025) · BIO Integration · doi:10.15212/bioi-2025-0034 · Cited by 11
“The Emb proteins include EmbA, EmbB, and EmbC, and EMB resistance mutations are mainly located near the Emb binding site [83].”
Wu, Z., Tan, Q., Zhang, C., Zhao, Y., Liao, Q., Yu, M., Xu, L., Wang, J., Liang, H., Li, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.959911 · Cited by 11
“This makes it a key drug in firstline anti-TB treatment (Zhang et al., 2020).”
BackgroundSelf-citationStructural biology and inhibition of the Mtb cell wall glycoconjugates biosynthesis on the membrane
Zhang, L., & Rao, Z. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102670 · Cited by 11
Self-citationSavková, K., Huszár, S., Baráth, P., Pakanová, Z., Kozmon, S., Vancová, M., Tesařová, M., Blaško, J., Kaliňák, M., Singh, V., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023663118 · Cited by 16
Maleki, M. R. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s542287 · Cited by 13
Bellanca, C. M., Polosa, S. P., Augello, E., Benedetto, G. D., Burgaletto, C., Cantone, A. F., Gaudio, G., Nunnari, G., Campagna, D., Nailes, J. M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1606150 · Cited by 10
Italia, A., Shaik, M. M., & Peri, F. (2023) · Biomolecules · doi:10.3390/biom13060999 · Cited by 9
Linhares, L. D. A., Peixoto, A. D. S., de Sousa, L. D. Â. C., Laet, J. P. D. L., Santos, A. C. D. S., Pereira, V. R. A., Neves, M. M. C., Ferreira, L. F., Hernandes, M. Z., de la Vega, J., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115579 · Cited by 9
M. avium Complex Pulmonary Infections: Therapeutic Obstacles and Progress in Drug Development
Charrier, E. S. A., Dassonville‐Klimpt, A., Andréjak, C., & Sonnet, P. (2025) · Pharmaceuticals · doi:10.3390/ph18060891 · Cited by 8
“EMB inhibits the activity of three arabinosyl transferases (EmbA, EmbB and EmbC), responsible for transferring arabinose to the growing arabinogalactane polymer, a crucial component of the mycobacterial cell wall [36,37].”
Antibiotic Mechanisms and Resistance: Molecular Insights and Therapeutic Strategies
Ma, H., Zhang, L., Wang, L., Yang, Z., Liu, J., Sun, H., Ge, S., & Quan, C. (2026) · Antibiotics · doi:10.3390/antibiotics15040351 · Cited by 9
“Structural studies revealed that EMB competitively occupies the arabinose donor/acceptor site of Emb enzymes, disrupting arabinan elongation [50].”
Self-citationZahra, N. U. A., Vagiona, A.-C., Uddin, R., & Andrade-Navarro, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814050 · Cited by 10
“Emb proteins are proposed to be the target of the anti-tuberculosis drug ethambutol, which inhibits arabinosyltransferases and, consequently, cell wall biogenesis [28].”
BackgroundXu, H., Xu, M., Chen, F., Chen, H., Du, W., & Yu, J. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-03843-0 · Cited by 8
“Secondly, MTBC possesses a robust cell wall comprising mycolic acid, peptidoglycan, lipoarabinoglycan, and arabinogalactan [44], which provide natural protection against external factors, including DNA extraction methods.”
Tsutsumi, H., Katsuyama, Y., Tezuka, T., Miyano, R., Inahashi, Y., Takahashi, Y., Nakashima, T., & Ohnishi, Y. (2021) · ChemBioChem · doi:10.1002/cbic.202100517 · Cited by 8
Stampolaki, Μ., Stylianakis, I., Zgurskaya, H. I., & Kolocouris, A. (2023) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-023-00504-6 · Cited by 8
“Ethambutol has been suggested to inhibit Mtb by binding to the membrane-embedded Emb proteins, EmbB and EmbC, involved in arabinan biosynthesis, [14] while SQ109 (1a) has been suggested that targets the trehalose monomycolate transporter, Mycobacterial membrane protein Large 3 (MmpL3), [4, 5] and like ethambutol, inhi…”
BackgroundWun, S. J., Tan, L., Lonhienne, T. G. A., Low, Y. S., Josh, P. F., Kuo, A., Smith, M. T., Gao, Y., Pierens, G. K., Guddat, L. W., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01028 · Cited by 6
Self-citationIdentification of inhibitors of UDP-galactopyranose mutase via combinatorial in situ screening
Fu, J. H., Fu, H., Xia, Y., N’Go, I., Cao, J., Pan, W., & Vincent, S. P. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00138h · Cited by 8
Hart, E. M., Lyerly, E., & Bernhardt, T. G. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011127 · Cited by 8
Mejia-Santana, A., Collins, R. R. J., Doud, E. H., & Landeta, C. (2025) · mBio · doi:10.1128/mbio.01083-25 · Cited by 8
Lepori, I., Liu, Z. W., Evbarunegbe, N. I., Feng, S., Brown, T. P., Mane, K., Dash, R., Shivangi, Wong, M., Naick, A., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02412-5 · Cited by 10
“Indeed, we found that a sub-inhibitory dose of ethambutol, an antibiotic that indirectly disrupts the mycomembrane 44,45 , does not potentiate JSF-2985 activity against Mtb (Fig.”
The Gene and Regulatory Network Involved in Ethambutol Resistance in Mycobacterium tuberculosis
Boni, F. G., Hamdi, I., Koundi, L. M., Dai, Y., Shrestra, K., Abo-Kadoum, M. A., Moure, U. A. E., Suleiman, I. M., & Xie, J. (2022) · Microbial Drug Resistance · doi:10.1089/mdr.2021.0239 · Cited by 8
Reshetnikov, K., Bykova, D., Kuleshov, K. V., Chukreev, K., Guguchkin, E., Акимкин, В. Г., Neverov, A. D., & Fedonin, G. G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1586476 · Cited by 7
“Ethambutol embA, embB, embC, embR, iniA, iniC, manB, rmlD, ubiA [9, 13, 62, 63]”
Arabinogalactan enhances Mycobacterium marinum virulence by suppressing host innate immune responses
Li, Y.-Y., Liu, H.-M., Wang, D., Lu, Y., Ding, C., Zhou, L., Wu, X., Zhou, Z.-W., Xu, S., Chen, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879775 · Cited by 9
“Mycobacterial resistance to some drugs also depends on cell wall structure (41).”
BackgroundSelf-citationChauhan, A., Singh, N. K., Kumar, R. P., Kushwaha, N. K., Prajapati, V. M., & Singh, S. K. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102352 · Cited by 7
Carter, J. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.14.460353 · Cited by 10
Gessese, A. T., Kinde, M. Z., Eshetu, T., & Kerisew, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-01241-6 · Cited by 6
“Previous reports showed that codon 306 was shown to be directly involved in EMB binding while codons 406 and 497 were not directly involved 78,79 .”
Cryo-EM structures of a mycobacterial ABC transporter that mediates rifampicin resistance
Wang, Y., Gao, S., Wu, F.-Y., Gong, Y., Mu, N., Wei, C., Wu, C., Wang, J., Yan, N., Yang, H., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403421121 · Cited by 6
“CLs have been shown to be enriched in the mycobacterial plasma membrane (34, 35) and have appeared in the structures of other membrane proteins found in mycobacteria (36, 37).”
Self-citationEmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin
He, J., Gao, Y., Wang, J., Hameed, H. M. A., Wang, S., Fang, C., Tian, X., Zhang, J., Han, X., Ju, Y., et al. (2024) · mLife · doi:10.1002/mlf2.12139 · Cited by 6
“Ultimately, this damages the cell wall's integrity and leads to cell death 15,16 .”
BackgroundSelf-citationStructural insights into polyisoprenyl-binding glycosyltransferases
Zinkle, A. P., Morgan, R. T., Nygaard, R., & Mancia, F. (2025) · Structure · doi:10.1016/j.str.2025.01.003 · Cited by 6
Fu, J. H., He, Z., Fu, H., Xia, Y., N’Go, I., Lou, H., Wu, J., Pan, W., & Vincent, S. P. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116896 · Cited by 6
Synthesis and Antimycobacterial Assays of Some New Ethambutol Analogs
Abdelaziz, R., Dube, M., Mann, L., Richter, A., Robaa, D., Reiling, N., Abdel‐Halim, M., & Imming, P. (2025) · Molecules · doi:10.3390/molecules30030600 · Cited by 5
“…(AraTs). with Mycobacterium abscessus complex (MABC) and Mycobacterium avium They are trans-membrane (TM) proteins that add a D-arabinofuranose sugar moiety from decaprenyl-phosphoryl-D-arabinose (DPA) to the growing arabinogalactan (AG) and lipoarabinomannan (LAM) [5–7]. complex (MAC).”
Structures of ALG3/9/12 reveal the assembly logic of the N-glycan oligomannose core
Alexander, J. A. N., Chen, S., Mukherjee, S., de Capitani, M., Irobalieva, R. N., Rossi, L., Agrawal, P., Kowal, J., Meirelles, M. A., Aebi, M., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02164-7 · Cited by 6
A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens
Choudhery, S., DeJesus, M. A., Srinivasan, A., Rock, J. M., Schnappinger, D., & Ioerger, T. R. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011408 · Cited by 5
“…(subunits of DNA gyrase) would be expected to interact with fluoroquinolones like LEVO [30], EMB targets embABC in the arabinogalactan pathway [31, 32], CLR, LZD and STR bind to the ribosome and inhibit translation, which can be protected by rRNA methyltransferases [33–35], VAN binds to…”
BackgroundInfluentialLi, M., Wang, W., Xiao, T., Liu, H., Lin, S., Hang, H., Bo, X.-L., Nan, X.-T., Qian, C., Fan, X., et al. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03821-y · Cited by 6
“As an arabinose analogue, EMB effectively interferes with the arabinosyl transferase encoding by the embCAB operon, which is involved in polymerizing arabinose into the arabinan components of arabinogalactan and lipoarabinomannan [2].”
Xiao, G., Cui, Y., Zhou, L., Niu, C., Wang, B., Wang, J., Zhou, S., Pan, M., Chan, C. K., Xia, Y., et al. (2025) · mLife · doi:10.1002/mlf2.12169 · Cited by 6
“One limitation to note is that the proteomics was not optimized to detect membrane ‐ embedded proteins, including the EMB targets 47 , EmbB and EmbA, thus potentially leading to inaccuracies in quantifying the arabinosyltransferase levels.”
Zhang, W., Shang, M., Qiu, L.-X., Liu, B., & Zang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417595 · Cited by 5
“Ethambutol dihydrochloride is a dihydrochloride that can inhibit the activity of arabi-nosyltransferase [23].”
BackgroundAntibiotic action revealed by real-time imaging of the mycobacterial membranePreprint
Wuo, M. G., Dulberger, C. L., Brown, R. A., Sturm, A., Ultee, E., Bloom‐Ackermann, Z., Choi, C., Garner, E. C., Briegel, A., Hung, D. T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.475452 · Cited by 5
“EMB inhibits the arabinofuranosyltransferases EmbA-C (21).”
The phenotypic landscape of the mycobacterial cellPreprint
Herrera, N., Todor, H., Kim, L. M., Burkhart, H. N., Billings, E., Fay, A., Warner, T. C., Lee, S. Y., Sayegh, N. Y., Bosch, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.688347 · Cited by 5
“Ethambutol is a first-line antituberculosis drug that, in M. smegmatis , acts by inhibiting the essential arabinosyltransferases EmbA and EmbB 58 .”
Flavonoids: Potential Novel Inhibitors of Mycobacterium tuberculosis
Kisimba, K., Kasumbwe, K., Odun-Ayo, F., & Faya, M. A. (2025) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265361578250504110100 · Cited by 5
“The main structure of the cell wall, mycolyl-arabinogalactan-peptidoglycan, is composed of long-chain mycolic acids, branched arabinogalactan, and cross-linked peptidoglycans [65].”
Pal, A., Pal, S., Mahapatra, S., Pandey, A., & Mohanty, D. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.11.054 · Cited by 6
Structural glycobiology – from enzymes to organelles
Mycroft‐West, C. J., Leanca, M. A., & Wu, L. (2025) · Biochemical Society Transactions · doi:10.1042/bst20241119 · Cited by 6
Self-citation
Metadata
- Authors
- Zhang, L., Zhao, Y., Gao, Y., Wu, L., Gao, R., Zhang, Q., Wang, Y., Wu, C., Wu, F., Gurcha, S. S., Veerapen, N., Batt, S. M., Zhao, W., Qin, L., Yang, X., Wang, M., Zhu, Y., Zhang, B., Bi, L., Zhang, X., Yang, H., Guddat, L. W., Xu, W., Wang, Q., Li, J., Besra, G. S., & Rao, Z.
- Affiliations
- Nankai University (CN)
- Chinese Academy of Sciences (CN)
- Tsinghua University (CN)
- ShanghaiTech University (CN)
- State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, College of Pharmacy, Nankai University, Tianjin 300353, China.
- University of Birmingham (GB)
- The University of Queensland (AU)
- ORCID
- Venue
- Science
- Published
- 2020-06-12
- Volume
- 368
- Issue
- 6496
- Pages
- 1211-1219
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3020603994
- Cited by
- 173
- References
- 61
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 28 · 2023: 31 · 2022: 22 · 2021: 20 · 2020: 9
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- DORA PSI (Paul Scherrer Institute) (submittedVersion)
- Funders
- National Medical Research Council (MR/S000542/1)
- National Key Research and Development Program of China Stem Cell and Translational Research (2017YFC0840300)
- Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000)
- Project of International Cooperation and Exchanges NSFC (81520108019)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Polysaccharides and Plant Cell Walls
- Keywords
- ethambutol, Mycobacterium tuberculosis, drug resistance, cell wall polysaccharides, enzyme-inhibitor binding, antitubercular agents, cryo-EM structure
- MeSH terms
- Antitubercular Agents, Cell Wall, Ethambutol, Mycobacterium tuberculosis, Pentosyltransferases, Protein Conformation, Cryoelectron Microscopy, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.